×
About 78 results

ALLMedicine™ Dermatologic Therapy Center

Research & Reviews  39 results

Challenges and strategies in dermatologic therapy-Personalized medicine, patient safety...
https://doi.org/10.1111/dth.13011
Dermatologic Therapy; Šitum M, Franceschi D et. al.

Jun 26th, 2019 - Skin conditions are among the most prevalent and disabling diseases affecting millions of people worldwide. Recently, there have been significant changes in dermatologic clinical practice. Advances in knowledge of disease pathophysiology have led ...

Treatment Outcomes of Immune-Related Cutaneous Adverse Events.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001790
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology; Phillips GS, Wu J et. al.

Jun 19th, 2019 - The aim of the current study was to report the efficacy of topical and systemic treatments for immune-related cutaneous adverse events (ircAEs) attributed to checkpoint inhibitors in an uncontrolled cohort of patients referred to oncodermatology c...

Representation and treatment allocation of racial groups in dermatologic therapy trials...
https://www.ncbi.nlm.nih.gov/pubmed/29630148
Dermatology Online Journal; Park CK, Alhusayen R

Apr 9th, 2018 - Although most investigators would agree that including minority races in clinical trials is important, recruitment and retention may differ among these populations. The objective of this review was to perform an audit of phase III dermatologic the...

General principles of dermatologic therapy and topical corticosteroid use
https://www.uptodate.com//contents/general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use
Beth G Goldstein

GENERAL PRINCIPLES The success of dermatologic therapies is dependent upon many factors. General issues related to topical therapies will be reviewed here with a particular emphasis upon the use of topical corticosteroids. There are five component...

Arsenic in Dermatology-From Dermatologic Therapy to Carcinogen.
https://doi.org/10.1001/jamadermatol.2017.2658
JAMA Dermatology; Shi CR, Nambudiri VE

Sep 13th, 2017 - Arsenic in Dermatology-From Dermatologic Therapy to Carcinogen.|2017|Shi CR,Nambudiri VE,|history,history,history,drug therapy,history,

see more →

Clinicaltrials.gov  39 results

Challenges and strategies in dermatologic therapy-Personalized medicine, patient safety...
https://doi.org/10.1111/dth.13011
Dermatologic Therapy; Šitum M, Franceschi D et. al.

Jun 26th, 2019 - Skin conditions are among the most prevalent and disabling diseases affecting millions of people worldwide. Recently, there have been significant changes in dermatologic clinical practice. Advances in knowledge of disease pathophysiology have led ...

Treatment Outcomes of Immune-Related Cutaneous Adverse Events.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001790
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology; Phillips GS, Wu J et. al.

Jun 19th, 2019 - The aim of the current study was to report the efficacy of topical and systemic treatments for immune-related cutaneous adverse events (ircAEs) attributed to checkpoint inhibitors in an uncontrolled cohort of patients referred to oncodermatology c...

Representation and treatment allocation of racial groups in dermatologic therapy trials...
https://www.ncbi.nlm.nih.gov/pubmed/29630148
Dermatology Online Journal; Park CK, Alhusayen R

Apr 9th, 2018 - Although most investigators would agree that including minority races in clinical trials is important, recruitment and retention may differ among these populations. The objective of this review was to perform an audit of phase III dermatologic the...

General principles of dermatologic therapy and topical corticosteroid use
https://www.uptodate.com//contents/general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use
Beth G Goldstein

GENERAL PRINCIPLES The success of dermatologic therapies is dependent upon many factors. General issues related to topical therapies will be reviewed here with a particular emphasis upon the use of topical corticosteroids. There are five component...

Arsenic in Dermatology-From Dermatologic Therapy to Carcinogen.
https://doi.org/10.1001/jamadermatol.2017.2658
JAMA Dermatology; Shi CR, Nambudiri VE

Sep 13th, 2017 - Arsenic in Dermatology-From Dermatologic Therapy to Carcinogen.|2017|Shi CR,Nambudiri VE,|history,history,history,drug therapy,history,

see more →